Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Markman Biologics logo — Advancing the future of wound healing with innovative tissue...

Markman Biologics

Advancing the future of wound healing with innovative tissue graft solutions

Founded 2017 Seed Total: $223.00K Biotechnology, Health Care +1

General Information

Company Name Markman Biologics
Founded Year 2017
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Markman Biologics. To contact Markman Biologics, visit markmanbiologics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Markman Biologics compare?

A PDF of Markman Biologics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Markman Biologics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Markman Biologics

Markman Biologics is a pioneering biotechnology firm that has secured a series of unique patents related to Micro Resurfacing for both internal and external medical reconstructive tissue grafts. The company's mission focuses on expanding and enhancing its application across a variety of wound healing scenarios. Founded in 2017, Markman Biologics aims to lead the industry through continuous improvement in their medical applications, setting a high standard for excellence. Their slogan, "Advancing the future of wound healing with innovative tissue graft solutions," encapsulates their commitment to pushing the boundaries of medical technology. Their last investment, a $223.00K Seed Round investment on 05 November 2019, underscores the potential that investors see in their innovative approach. Markman Biologics operates in the Biotechnology and Health Care industries, leveraging their patents and mission to make a significant impact. While the specific location of their headquarter is not provided, their focus on cutting-edge biotechnology suggests a presence in key medical and research hubs. The absence of disclosed investors for their last investment round leaves room for speculation regarding potential backers and strategic partners. As a biotechnology startup, Markman Biologics possesses the potential to revolutionize wound healing and medical reconstructive treatments. Their series of patents and focused mission indicate a path toward industry leadership, while their recent investment reaffirms investor confidence in their vision. With continuous improvement and innovation as their guiding principles, Markman Biologics is undoubtedly a company to watch in the evolving field of biotechnology.

Business keywords: Tissue grafts, Medical applications, Wound healing, Micro resurfacing, Reconstructive surgery, Patents, Innovation, Medical technology, Biomedical engineering

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $223.00K -
05 Nov 2019

Markman Biologics Alternatives & Competitors

View All Alternatives
Markman Biologics vs
Evergen (Formerly Collagen Solutions)
Evergen (Formerly Collagen Solutions) United States

Materials for Life

Post-IPO Equity
87 employees
Biotechnology, Medical Devices
Markman Biologics vs
Industrie Biomediche Insubri SA
Industrie Biomediche Insubri SA Switzerland

IBI-SA is a hi-tech Swiss biomedical company focused on regenerative medicine.

Series A
14 employees
Biotechnology, Medical Devices
Markman Biologics vs
TISSIUM
TISSIUM France

Biomorphic Programmable Polymers

Series D
132 employees
Biotechnology, Health Care
Also compare with: Markman Biologics vs RedDress Ltd. RedDress Ltd. View all alternatives

FAQ About Markman Biologics

Advancing the future of wound healing with innovative tissue graft solutions
Markman Biologics was founded in 2017.
Markman Biologics operates in Biotechnology, Health Care and Medical Devices. Its work centres on Tissue grafts, Medical applications, Wound healing and Micro resurfacing.
Markman Biologics has completed 1 funding round, raising a total of $223.00K. The latest funding stage is Seed.
Top alternatives and competitors to Markman Biologics include Evergen (Formerly Collagen Solutions), Industrie Biomediche Insubri SA, TISSIUM, Profusa, Nova Plasma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Markman Biologics and Evergen (Formerly Collagen Solutions) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Markman Biologics, https://bouncewatch.com/company/markman-biologics, updated 11 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout